For preventing memory decline or dementia, no supplement has good evidence: ginkgo's six-year, 3,069-person GEM trial found no effect, and B vitamins, vitamin E, omega-3 and multivitamins have failed or produced only marginal, unreplicated cognitive findings in large trials. For modest enhancement, bacopa shows small delayed-recall improvements in small 12-week trials; phosphatidylserine and lion's mane have thin, preliminary data. Correcting genuine deficiencies — vitamin B12, and omega-3 in people who never eat fish — is the exception where supplements plainly help. The interventions with real evidence are exercise, sleep, treating hearing loss, blood pressure control, and mental and social engagement.
The scorecard
The memory aisle makes two different promises — prevent decline and sharpen now — and the evidence for each, ingredient by ingredient:
| Ingredient | Verdict | What trials show |
|---|---|---|
| Ginkgo biloba | Mixed, prevention negative | GEM: 3,069 adults, 240 mg/day, six years — no effect on dementia or decline. Mixed European data in diagnosed dementia only. No enhancement in healthy adults. |
| Bacopa monnieri | Limited | Small 8–12-week trials repeatedly show modest delayed-recall improvement at 300–450 mg/day standardized extract. No large confirmation. |
| Vitamin B12 | Deficiency-dependent | Deficiency causes reversible cognitive impairment; correcting it works. Supplementing the replete does nothing for memory. |
| B6/B12/folate combos | Insufficient | Lower homocysteine reliably; cognitive outcomes in large trials essentially null. |
| Omega-3 (fish oil) | Mixed, mostly null | Large trials in well-nourished older adults negative; plausible only where dietary intake is very low. |
| Vitamin E | Insufficient | High-dose trials: no prevention; modest functional slowing in one Alzheimer's treatment trial; high doses carry bleeding concern. |
| Phosphatidylserine | Insufficient | Small older trials (some using a discontinued bovine form) suggested benefit; modern soy-derived data thin. |
| Lion's mane | Insufficient | A couple of tiny trials; mechanism talk far ahead of human data. |
| Curcumin | Insufficient | A small positive trial amid absorption problems and failures; unsettled. |
| Multivitamins | Mixed | One recent large trial reported a small memory-score benefit in older adults; earlier large trials found nothing. Not yet a recommendation. |
| Caffeine (+ L-theanine) | Works, transiently | Genuine acute alertness and attention effects — a beverage fact, not brain protection. |
| Apoaequorin (Prevagen) | Insufficient | Digested protein, implausible mechanism, litigation-grade evidence. |
Pattern across the table: the famous names earned large trials and failed them; the residual "maybes" are small-trial ingredients (bacopa foremost) whose effects, if real, are modest; and the clear wins are corrections of deficiency states, which is medicine, not enhancement.
Why the brain resists the capsule
Age-related memory change and dementia are decades-long processes of vascular wear, protein accumulation and lost reserve — the reason single-molecule fixes keep failing, and the reason the successful levers are the ones acting on vessels, stimulation and reserve for years at a time. It is also why any product promising day-one transformation has told you what it is.
What actually has evidence
The unpurchasable list, each with better data than anything in the table:
- Aerobic exercise — improves attention, processing speed and memory in trials, and associates with lower dementia risk.
- Sleep, quantity and apnea treatment — memory consolidation happens there; see brain fog for the overlap.
- Hearing correction — hearing loss is a leading modifiable dementia risk factor, and a large recent trial found hearing aids slowed decline in higher-risk older adults.
- Blood pressure control in mid-life — intensive treatment reduced mild cognitive impairment in a major trial.
- Managing diabetes, smoking, alcohol — the vascular trio.
- Mental and social engagement — reserve is built by use.
If you still want to experiment
The defensible short list: bacopa 300 mg/day standardized, judged honestly at twelve weeks; B12 tested, then treated if low rather than supplemented blind; fish twice a week over capsules; coffee enjoyed for what it does do. Skip proprietary "brain blends" — under-dosed copies of this table with ginkgo's interactions included. And any objective memory failure — missed obligations, repeated questions, getting lost — is a doctor's visit, not a purchase; a treatable cause list (B12, thyroid, depression, medications, apnea) is waiting to be checked. Our brain supplement research holds the product-by-product findings.
Frequently asked questions
What about Prevagen and other heavily advertised brands?
Prevagen's ingredient is apoaequorin, a jellyfish protein that is digested like any dietary protein and has no plausible route to the brain; its supporting "study" found benefit only in after-the-fact subgroup slicing, and US regulators sued over the advertising. Heavily advertised memory brands are advertising phenomena. Judge any product by its named ingredients against the table here.
Do omega-3 / fish oil pills protect the brain?
Large trials in older adults with adequate diets show no cognitive protection from fish-oil capsules. Observational data favor fish eaters, and low omega-3 status is the one context with a plausible case — so eat fish twice a week, and reserve capsules for people who never do.
Is there anything to lion's mane?
A famous mushroom with mostly laboratory and animal data; human evidence is a couple of very small trials (one in older adults with mild impairment showed score improvements that faded after stopping). Interesting, unproven, and sold far ahead of its data.
Can any supplement lower dementia risk at all?
None demonstrated. The exceptions prove the rule: correcting B12 deficiency treats a reversible cause of cognitive impairment, and managing blood pressure, hearing, activity, smoking and diabetes — none of them supplements — are the levers population science supports for risk reduction.
References
- NCCIH. Ginkgo (2020). https://www.nccih.nih.gov/health/ginkgo
- National Institute on Aging. Memory Problems, Forgetfulness, and Aging (2023). https://www.nia.nih.gov/health/memory-loss-and-forgetfulness/memory-problems-forgetfulness-and-aging
- National Institute on Aging. What Is Alzheimer's Disease? (2023). https://www.nia.nih.gov/health/alzheimers-and-dementia/what-alzheimers-disease
- NIH Office of Dietary Supplements. Vitamin B12 — Fact Sheet for Health Professionals (2024). https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/
This page discusses supplement ingredients or categories. It may mention a commercial product, with disclosure. It is general health information, not personal medical advice. Read our editorial policy and medical review policy.